AnnovisBio has initiated a 6-month Phase ... - Cure Parkinson's

Cure Parkinson's

26,491 members27,905 posts

AnnovisBio has initiated a 6-month Phase 3 study to evaluate 2 different doses Buntanetap (posiphen) in 450 participants with PD

12 Replies

AnnovisBio has initiated a 6-month, placebo-controlled, double-blind Phase 2 study to evaluate efficacy, safety, & tolerability of 2 different doses their agent Buntanetap (posiphen) in 450 participants with #Parkinsons

clinicaltrials.gov/ct2/show...

twitter.com/ScienceofPD/sta...

12 Replies
Boscoejean profile image
Boscoejean

location?

in reply toBoscoejean

clinicaltrials.gov/ct2/show...

WinnieThePoo profile image
WinnieThePoo

Oh boy life gets confusing. I'm sure it was early this year that the news was the fda had approved phase 3 trials following successful phase 2 trials450 participants is a big phase 2

in reply toWinnieThePoo

at least it is a 6 months study...

jeffreyn profile image
jeffreyn

Is "Phase 2" a typo?

This looks very similar to their Phase 3 trial outline posted a couple of days ago.

healthunlocked.com/cure-par...

in reply tojeffreyn

yes, you might be right....both are enrolling 450 patients, could it be a coincidence?

jeffreyn profile image
jeffreyn in reply to

It's not just the "450 patients" that is the same.

"The Company announced the trial design of the upcoming Phase 3 trial evaluating buntanetap in early PD. The study is designed to enroll 450 PD patients with Hoehn & Yahr scale scores of 1, 2 and 3 and randomize them at 1:1:1 ratio into placebo, 10mg or 20mg buntanetap once daily on top of their standard of care for six months."

irpages2.eqs.com/websites/a...

in reply tojeffreyn

fixed the title to say phase 3.

jeffreyn profile image
jeffreyn

In the title they say "double-blind", but in the "Brief Summary" they also say "open-label".

"The total duration of open-label study participation will be 6-7 months."

I assume that means 6 months double blind followed by 6-7 months open label.

clinicaltrials.gov/ct2/show...

jeffreyn profile image
jeffreyn in reply tojeffreyn

They have changed this sentence to now say "The total duration of study participation will be 7-8 months."

yes it was a typo, they fixed it to Phase 3

jeffreyn profile image
jeffreyn

They have changed the completion dates to something more realistic.

Estimated Primary Completion Date: June 2023

Estimated Study Completion Date: December 2023

Not what you're looking for?

You may also like...

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.